Deva Holding A.S. (IST:DEVA)

Market Cap	12.62B
Revenue (ttm)	14.59B
Net Income (ttm)	300.30M
Shares Out	200.02M
EPS (ttm)	1.50
PE Ratio	42.03
Forward PE	n/a
Dividend	0.29 (0.46%)
Ex-Dividend Date	n/a

Volume	329,461
Average Volume	518,629
Open	62.95
Previous Close	63.10
Day's Range	62.50 - 63.65
52-Week Range	51.00 - 80.60
Beta	-0.52
RSI	52.36
Earnings Date	Mar 6, 2026

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.